S2Medical AB (publ) (FRA:S21)
Germany flag Germany · Delayed Price · Currency is EUR
0.0003
+0.0001 (50.00%)
At close: Nov 28, 2025

S2Medical AB Company Description

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden.

The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.

It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications.

In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge.

The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

S2Medical AB (publ)
CountrySweden
Founded2013
IndustryOrthopedic, Prosthetic, and Surgical Appliances and Supplies
Employees7
CEOPetter Sivler

Contact Details

Address:
Sunnorpsgatan 5
Linköping, 582 73
Sweden
Phone46 87 00 00 50
Websites2m.se

Stock Details

Ticker SymbolS21
ExchangeFrankfurt Stock Exchange
Share ClassClass B Shares
Fiscal YearJanuary - December
Reporting CurrencySEK
SIC Code3842

Key Executives

NamePosition
Petter SivlerChief Executive Officer
Marten SkogChief Operating Officer